Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 03:12PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
No apologies necessary. That note is confusing AF.
I'm happy with my holdings as is, so I guess we'll see.
Wonder if that note is what caused the trading activity today though, lol